Skip to content

Epsilon Digoxin Test Kit

by Beckman Instruments, Inc. 510(k)

Active United States

510(k) K842655

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK842655 Date16 Aug 1984ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
KXT
Device Class
Class II
Regulation
21 CFR Part 862.3320
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

An enzyme immunoassay device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy.

The device is supplied as a test kit and is classified as a Class II medical device under FDA regulation number 862.3320. It received traditional 510(k) clearance (K842655) on August 16, 1984, following a 37-day review, and is substantially equivalent to a legally marketed predicate device.

Other devices from Beckman Instruments, Inc.

See all devices from Beckman Instruments, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Epsilon Digoxin Test Kit used for?

    The Epsilon Digoxin Test Kit is an enzyme immunoassay device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy.

  • How is the Epsilon Digoxin Test Kit supplied and what is its classification?

    The device is supplied as a test kit and is classified as a Class II medical device under FDA regulation number 862.3320. It received traditional 510(k) clearance (K842655) on August 16, 1984, following a 37-day review, and is substantially equivalent to a legally marketed predicate device.

  • What regulatory pathway was used for the Epsilon Digoxin Test Kit and what was the outcome?

    The Epsilon Digoxin Test Kit received traditional 510(k) clearance (K842655) on August 16, 1984, following a 37-day review. The decision code was SESE, indicating it was found substantially equivalent to a legally marketed predicate device under FDA regulation 862.3320.